Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs145584710 | chr2:29516296 | T/TA | 0 | 134 | 43.68 | 24.23 | 0.57 | KM Plot |
| TGCT | rs146598431 | chr16:67646396 | G/T | 0 | 133 | 46.07 | 24.1 | 0.57 | KM Plot |
| TGCT | rs146761481 | chr20:44794208 | CAATA/C | 0.000157 | 132 | 37.62 | 70.6 | 33.45 | KM Plot |
| TGCT | rs1472526 | chr5:1776840 | G/A | 3.93E-6 | 128 | 43.68 | 41.97 | 46.3 | KM Plot |
| TGCT | rs147586807 | chr16:67629452 | GTCT/G | 0 | 133 | 46.07 | 24.1 | 0.57 | KM Plot |
| TGCT | rs148233139 | chr17:39392227 | T/TAG | 8.92E-7 | 131 | 13.17 | 36.63 | 43.68 | KM Plot |
| TGCT | rs148266593 | chr10:27593480 | G/C | 0 | 127 | 42.18 | 45.83 | 18.85 | KM Plot |
| TGCT | rs148539693 | chr2:9732516 | ATCT/A | 5.47E-5 | 133 | 43.68 | 41.97 | 27.33 | KM Plot |
| TGCT | rs148679398 | chr14:78254652 | C/T | 7.3E-5 | 134 | 45.83 | 37.95 | 18.07 | KM Plot |
| TGCT | rs148916699 | chr6:15252083 | C/T | 3.36E-5 | 133 | 37.7 | 45.93 | NA | KM Plot |
| TGCT | rs148966697 | chr6:156982132 | T/TAAC | 0.000115 | 133 | 41.27 | 60.63 | 59.27 | KM Plot |
| TGCT | rs149079055 | chr5:42531351 | A/G | 9.12E-5 | 133 | 37.7 | 52.43 | 20.23 | KM Plot |
| TGCT | rs149370723 | chr6:15248332 | C/T | 3.68E-5 | 132 | 37.95 | 45.93 | NA | KM Plot |
| TGCT | rs149707159 | chr1:14576969 | GC/G | 8.86E-7 | 133 | 42.27 | 28.8 | 0.57 | KM Plot |
| TGCT | rs150100093 | chr4:154729074 | T/TG | 8.84E-5 | 134 | 40.57 | 42.1 | 50.9 | KM Plot |